tm logo

Monitor this mark

View On USPTO

AFLIMAB
Live/Registered
REGISTERED

on 05 Jan 2021

Last Applicant/ Owned by

Klinge Biopharma GmbH

83607 Holzkirchen

DE

Serial Number

79276761 filed on 09th Dec 2019

Registration Number

6235846 registered on 05th Jan 2021

in the Principal Register

Correspondent Address

Charles T. J. Weigell

Charles T. J. Weigell Fross Zelnick Lehrman & Zissu, P.C.

New York, NY 10036

UNITED STATES

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

AFLIMAB

Pharmaceutical preparations for the treatment of angiogenesis and ocular diseases and disorders; biologic medicines for the treatment of angiogenesis and ocular diseases and disorders

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations for the treatment of angiogenesis and ocular diseases and disorders; biologic medicines for the treatment of angiogenesis and ocular diseases and disorders

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 79276761

Mark Type

No Service/Collective Mark

Attorney Docket Number

No KPHG 2007010

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
26th May 2024NEW REPRESENTATIVE AT IB RECEIVED
01st Apr 2022NEW REPRESENTATIVE AT IB RECEIVED
04th Jun 2021NEW REPRESENTATIVE AT IB RECEIVED
02th May 2021FINAL DECISION TRANSACTION PROCESSED BY IB
08th Apr 2021FINAL DISPOSITION NOTICE SENT TO IB
08th Apr 2021FINAL DISPOSITION PROCESSED
05th Apr 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05th Jan 2021REGISTERED-PRINCIPAL REGISTER
20th Oct 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
20th Oct 2020PUBLISHED FOR OPPOSITION